Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Spink, B. C.
Right arrow Articles by Spink, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spink, B. C.
Right arrow Articles by Spink, D. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 11, 1947-1957, November 2000
© 2000 Oxford University Press


Cancer Biology

SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells

Barbara C. Spink1, Barbara H. Katz1, Mirza M. Hussain1, Shaokun Pang1,2, Steven P. Connor1, Kenneth M. Aldous1,2, John F. Gierthy1,2 and David C. Spink1,2,3

1 Wadsworth Center, New York State Department of Health, Albany,NY 12201-0509 and
2 Department of Environmental Health and Toxicology, University at Albany, State University of New York, Albany,NY 12201-0509, USA

In a previous study of nine human breast-derived cell lines, rates of metabolism of 17ß-estradiol (E2) were greatly enhanced when cultures were exposed to the aromatic hydrocarbon receptor agonist, 2,3,7,8-tetrachlorodibenzo-p-dioxin. Elevated rates of E2 hydroxylation at the C-2, -4, -6{alpha} and -15{alpha} positions were observed concomitant with the induction of cytochromes P450 1A1 and 1B1. In each cell line, 2- and 4-hydroxyestradiol (2- and 4-OHE2) were converted to 2- and 4-methoxyestradiol (2- and 4-MeOE2) by the action of catechol O-methyltransferase. In this study, conjugation of these estrogen metabolites was investigated. A comparison of the levels of metabolites determined with and without prior treatment of the media with a crude ß-glucuronidase/sulfatase preparation showed that most of the 2-MeOE2 present was in conjugated form, whereas 4-MeOE2, 6{alpha}-OHE2 and 15{alpha}-OHE2 were minimally conjugated. Inhibitor studies suggested that it was the sulfatase activity of the preparation that hydrolyzed the 2-MeOE2 conjugates in MCF-7 cell media; the presence of 2-MeOE2-3-sulfate in MCF-7 culture media was confirmed by electrospray ion-trap mass spectrometry. To identify the enzyme catalyzing this conjugation, the expression of mRNAs encoding five sulfotransferases (SULT1A1, SULT1A2, SULT1A3, SULT1E1 and SULT2A1) was evaluated in the nine cell lines by use of the reverse transcription–polymerase chain reaction. Only expression of SULT1A1 mRNA correlated with the observed conjugation of nanomolar levels of 2-MeOE2 in these cell lines. Cloning and sequencing of SULT1A1 cDNA from MCF-7 cells revealed that mRNAs encoding two previously identified allelic variants, SULT1A1*1 (213Arg) and SULT1A1*2 (213His), were expressed in these cells. Heterologous cDNA-directed expression of either variant in MDA-MB-231 cells, which do not normally express SULT1A1, conferred 2-MeOE2 sulfonation activity. The SULT1A1 allelic variants were also expressed in Sf9 insect cells, from which post-microsomal supernatants were used to determine Km values of 0.90 ± 0.12 and 0.81 ± 0.06 µM for SULT1A1*1 and SULT1A1*2, respectively, with 2-MeOE2 as substrate. These results show that SULT1A1 is an efficient and selective catalyst of 2-MeOE2 sulfonation and, as such, may be important in modulating the anticarcinogenic effects of 2-MeOE2 that have been described recently.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. K. Holt, M. A. Rossing, K. E. Malone, S. M. Schwartz, N. S. Weiss, and C. Chen
Ovarian Cancer Risk and Polymorphisms Involved in Estrogen Catabolism
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 481 - 489.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-h. Meng, U. Shankavaram, C. Chen, K. Agama, H.-q. Fu, F. J. Gonzalez, J. Weinstein, and Y. Pommier
Activation of Aminoflavone (NSC 686288) by a Sulfotransferase Is Required for the Antiproliferative Effect of the Drug and for Induction of Histone {gamma}-H2AX
Cancer Res., October 1, 2006; 66(19): 9656 - 9664.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Nagar, S. Walther, and R. L. Blanchard
Sulfotransferase (SULT) 1A1 Polymorphic Variants *1, *2, and *3 Are Associated with Altered Enzymatic Activity, Cellular Phenotype, and Protein Degradation
Mol. Pharmacol., June 1, 2006; 69(6): 2084 - 2092.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuchi, and H. Sasano
Sex steroid-producing enzymes in human breast cancer
Endocr. Relat. Cancer, December 1, 2005; 12(4): 701 - 720.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Nowell, D. L. Ratnasinghe, C. B. Ambrosone, S. Williams, T. Teague-Ross, L. Trimble, G. Runnels, A. Carrol, B. Green, A. Stone, et al.
Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. C. Spink, B. H. Katz, M. M. Hussain, B. T. Pentecost, Z. Cao, and B. C. Spink
Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells
Carcinogenesis, December 1, 2003; 24(12): 1941 - 1950.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Chauhan, G. Li, D. Auclair, T. Hideshima, P. Richardson, K. Podar, N. Mitsiades, C. Mitsiades, C. Li, R. S. Kim, et al.
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays
Blood, May 1, 2003; 101(9): 3606 - 3614.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.